- Zacks Small Cap Research•28 minutes ago
By Brian Marckx, CFA OTC:STLT NASDAQ:CNAT NYSE:PFE NYSE:BMY NYSE:SNY Spotlight Teams With Researchers Credited With Breakthrough Zika Drug Findings Researchers from Florida State University, Johns Hopkins ...
- Motley Fool•2 hours ago
An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation shares this week.
- Investor's Business Daily•18 hours ago
Bowing to political pressure, Mylan's generics arm will sell a cut-rate version of its own best-selling product.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||34.92 x 2000|
|Ask||34.93 x 6300|
|Day's Range||34.85 - 35.18|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||30.95|
|Avg Vol (3m)||21,923,770|
|Dividend & Yield||1.20 (3.45%)|